Form 4 for RH RH
Accepted 2022-11-17 00:00:00 ET · period of report 2022-11-15 · accession 0001415889-22-011527 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-17 | 2022-11-15 | RH | Lee Edward T | SEE REMARKS | S - Sale+OE | $300.00 | -2,190 | 2,624 | -45% | -$657.0K |
| DM | 2022-11-17 | 2022-11-15 | RH | Lee Edward T | SEE REMARKS | M - OptEx | $107.60 | +2,190 | 3,164 | +225% | +$235.6K |
| DM | 2022-11-17 | 2022-11-15 | RH | Lee Edward T | SEE REMARKS | M - OptEx | $0.00 | -2,190 | 3,200 | -41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-15 | S | D | 1,250 | $300.00 | 2,624 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-15 | M | A | 1,250 | $101.25 | 3,874 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| 3 | Common | Common Stock | 2022-11-15 | M | A | 400 | $154.82 | 3,024 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| 4 | Common | Common Stock | 2022-11-15 | S | D | 540 | $300.00 | 2,624 | D | — | — | |
| 5 | Common | Common Stock | 2022-11-15 | M | A | 540 | $87.31 | 3,164 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| 6 | Common | Common Stock | 2022-11-15 | S | D | 400 | $300.00 | 2,624 | D | — | — | |
| 7 | Derivative | Employee Stock Option (right to buy) | 2022-11-15 | M | D | 540 | $0.00 | 0 | D | $87.31 · — to 2025-05-05 | 540 Common Stock | (F2) Option vested in five equal annual installments beginning on 5/6/2016 and ending on 5/6/2020. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2022-11-15 | M | D | 1,250 | $0.00 | 3,000 | D | $101.25 · — to 2029-04-01 | 1,250 Common Stock | (F4) In the Form 4 filed for the Reporting Person on April 20, 2022, such Form 4 inadvertently reported in column 9 that 1,250 shares remained subject to this option following exercise as reported in such Form 4. Such Form 4 should have reported in column 9 that 4,250 shares remained subject to this option following exercise. This has been corrected in this Form 4 by reflecting that 3,000 shares remain subject to this option following the Reporting Person's exercise of the employee options for 1,250 shares on November 15, 2022. (F3) This option award is vested and exercisable with respect to 1250 of the shares and will vest and become exercisable with respect to an additional 1000 shares on April 2, 2023, and an additional 2000 shares on April 2, 2024, subject to continuous service. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2022-11-15 | M | D | 400 | $0.00 | 3,200 | D | $154.82 · — to 2030-04-28 | 400 Common Stock | (F5) This stock option award is vested and exercisable with respect to 400 of the shares and will vest and become exercisable with respect to an additional 400 shares on April 29, 2023, an additional 600 shares on April 29, 2024, an additional 600 shares on April 29, 2025, an additional 800 shares on April 29, 2026, and an additional 800 shares on April 29, 2027, subject to continuous service. |